Conly S. Wythers

Conly S. Wythers is Counsel at Rakoczy Molino Mazzochi Siwik LLP (RMMS), a firm recognized for its extensive expertise in life sciences intellectual property. His practice is primarily concentrated on intellectual property litigation, with a particular emphasis on patent infringement suits arising under the Hatch-Waxman Amendments to the Federal Food, Drug, and Cosmetic Act. Mr. Wythers has technical experience across a broad spectrum of pharmaceutical products and technologies, including inhalants, injectables, ophthalmics, solid oral dosage forms, and various topical dosage forms. Beyond patent matters, he has also represented clients in other areas such as antitrust, breach of contract, and trade secret disputes.

In his patent litigation practice, Mr. Wythers has experience representing defendants. This is evidenced by his role as counsel for the defendant in Haemonetics Corporation v. Fresenius Kabi USA, LLC et al. His work in Hatch-Waxman litigation often involves defending companies in complex pharmaceutical patent disputes. He has been involved in all stages of litigation, from initial counseling through trial and appeal, encompassing discovery, depositions, claim construction, motions practice, and brief writing in U.S. district courts and the Federal Circuit.

The available information does not specify his regular involvement in inter partes review (IPR) or post-grant review (PGR) proceedings before the Patent Trial and Appeal Board (PTAB). He is a member of the American Bar Association, the Chicago Bar Association, and the American Intellectual Property Law Association.